Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 39,954 shares at $28.30 ($1.1M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $1.1M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.30 | 8,684 | $246K | 21.5% |
| 2 | $28.30 | 8,684 | $246K | 21.5% |
| 3 | $28.91 | 11,018 | $319K | 27.8% |
| 4 | $28.91 | 11,018 | $319K | 27.8% |
| 5 | $29.49 | 550 | $16K | 1.4% |
| Total | $28.65 avg | 39,954 |
| $1.1M |
| 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |